The unique challenges that face both oncology nurse navigators specializing in gastrointestinal cancer and patients with these diseases are reviewed in a presentation at the 2018 ONA Navigation Summit.
Creating a multidisciplinary breast clinic can ensure that patients with breast cancer receive care that is timely, effective, and efficient, according to a presentation at the 2018 ONA Navigation Summit.
Navigating Patients With Head and Neck Cancer: Important Roles and Responsibilities of the Oncology Nurse Navigator
The head and neck oncology nurse navigator (ONN) is a unique and critical position to help patients, their families, and their caregivers as they face their diagnosis and undergo treatment.
The technology will facilitate data entry for patient navigation activities, evaluation of one or more patient navigators (PNs), and generate reports.
Cost of cancer care is more than co-pays for medications and treatment. Cancer can affect a patient's ability to work compounding the financial costs of their care, as described in this presentation at the 2018 ONA Navigation Summit.
A discussion and review of how to develop a successful nurse or patient navigation program is presented at the 2018 ONA Navigation Summit.
Oncology nurse navigators tend to forget the most important person in the cancer care continuum: themselves. In this keynote presentation at the 2018 ONA Navigation Summit, Deborah Boyle, RN, MSN, AOCNS®, FAAN, talks about the importance of self care.
Now well established within the cancer care continuum, this presentation at the 2018 ONA Navigation Summit discussed the forces expanding the use of oncology navigation as well as the evolving role of the oncology nurse navigator.
A study presented at the 2018 ASCO Annual Meeting investigated the mortality risk for patients with multiple myeloma who develop VTE.
An assessment of more than 71,000 patients with leukemia demonstrated the difference in outcomes for patients admitted to hospital on the weekend vs weekday. Findings were presented at the 2018 ASCO Annual Meeting.
An intervention utilizing lay health workers supervised by NPs lowered health care costs and improved patient satisfaction.
Researchers evaluated whether the development of irAEsc among patients with metastatic head and neck cancer who have failed platinum-based chemotherapy could improve patient outcomes.
Children's Oncology Group study reported on the effect of dexrazoxane on cardiotoxicity of anthracycline-containing regimens in pediatric patients with AML at the 2018 ASCO Annual Meeting.
In a multicenter phase 2 study, the Walk With Ease program was evaluated for its effectiveness in reducing radiotherapy-associated fatigue vs usual care in older patients with breast cancer. Results were presented at 2018 ASCO Annual Meeting.
Latest findings do not confirm an overall survival (OS) benefit found in a previous randomized phase 2 trial.
Study presented at 2018 ASCO Annual Meeting determined the feasibility of using a mindfulness intervention to improve quality of life and confidence in advance care planning discussions among patient-family caregiver dyads.
Consultations for palliative care for hospitalized highly symptomatic patients with cancer is low regardless of curability or whether patient has hematologic or solid cancer, a study presented at 2018 ASCO has shown.
Long-term analysis determined the effect of postadjuvant dose-dense chemotherapy on DLCO among women with breast cancer.
Survey results presented at the 2018 ASCO Annual Meeting demonstrated the effects of financial toxicity on patients with early stage breast cancer.
In a case study, olaparib was found to induce folate deficiency in most patients with relapsed ovarian cancer. Researchers discuss the significance of this adverse effect and how it was managed.
In fielding reports of CNS-related adverse effects from patients in the ambulatory infusion room, nurses were able to prompt a pharmacy practice review. The outcomes of the resulting switch in premedication for HSR was presented at the 2018 ONS Annual Congress.
A clinic staffed with clinical research nurses provided needed care for patients in clinical trials who experienced adverse effects, and also ensured consistent documentation of treatment-related AEs, according to a presentation at the 2018 ONS Annual Congress.
Researchers reported on their study that investigated the feasibility of operating a same-day clinic for urgent care for patients currently receiving cancer treatment. These results were presented at the 2018 ONS Annual Congress.
The importance of oncology clinical research nurses in the clinical trial process was explored in a study presented at the 2018 ONS Annual Congress.
Researchers sought to determine the effectiveness of a multimodal continuity of care program for women receiving radiation therapy for gynecologic or lower GI cancers. Their findings were presented at the 2018 ONS Annual Congress.
A study presented at the 2018 ONS Annual Congress explored the feasibility of an advanced practice nurse-led lung cancer screening program at ambulatory outpatient clinics.
A nursing staff worked together to identify and work a solution to a high rate of "near-misses" in chemotherapy administration, but further evaluation and additional interventions are needed to maintain the successful practice change, study findings presented at 2018 ONS Annual Congress have shown.
A project presented at the 2018 ONS Annual Congress demonstrated the effectiveness of standardizing nursing practices for paclitaxel infusions.
A newly developed web site, described in a presentation at the 2018 ONS Annual Congress, aims to help nurses and patients explore clinical trial options for patients with hematologic cancers.
That better informed patients can make better end-of-life decisions is well-known; however, nurse perception may be a barrier to earlier discussions. This project, presented at the 2018 ONS Annual Congress, sought to determine the effect of better informed nurses.
A study presented at the 2018 ONS Annual Congress explored whether patients can safely bypass SICU after HNC surgery, transferring directly from PACU to a specialized unit within the SO.
A review of oncology radiation nurse workload led to new benchmarks for staffing and reduced over/under staffing, according to a presentation at the 2018 ONS Annual Congress.
A nurse-drive protocol tackled the influenza and pneumococcal vaccine uptake rates at an NCI-designated comprehensive cancer center, according to a presentation at 2018 ONS Annual Congress.
A nursing staff workflow and capacity study resulted in an overhaul of nurse scheduling in an infusion clinic. Results were presented at the 2018 ONS Annual Congress.
A study results presented at the 2018 ONS Annual Congress demonstrated that incorporating scalp cooling with the Dignicap device prior to chemotherapy for breast cancer may reduce treatment-related alopecia.
Teaming up with multiple specialists to create an algorithm for managing AML in older patients improved clinician knowledge as well as provided patient-centered care, a presentation at 2018 ONS Annual Congress has shown.
A study presented at the 2018 ONS Annual Congress explored whether aromatherapy and reflexology can ease anxiety and pain for patients undergoing brachytherapy for cervical cancer.
Researchers assessed the effectiveness of low level laser therapy in preventing or minimizing oral mucositis in patients with hematologic cancers preparing to undergo HSCT. Results were presented at the 2018 ONS Annual Congress.
Nurses who completed training and practiced CONNECT were interviewed to glean their perspective of the intervention on their personal and professional fulfillment. Results were presented at the 2018 ONS Annual Congress.
Oncology extended care clinics were shown to significantly improve urgent care needs of patients with cancer without unnecessarily burdening the ED or compromising patient care, according to a presentation at the 2018 ONS Annual Congress.
A link between visual function, ocular symptoms, and quality of life was found in cross-sectional study of patients who underwent radiotherapy for head and neck cancers, according to a presentation at the 2018 ONS Annual Congress.
Results of a prospective, longitudinal study presented at 2018 ONS Congress demonstrate improvement from baseline to discharge patients with acute leukemia who receive induction chemotherapy in hospital.
Electronic Self-Report Assessment-Cancer May Preserve Physical Function in Chemotherapy-Induced Peripheral Neuropathy
Research presented at the 2018 ONS Congress reported on the effectiveness of ESRA-C, a web-based assessment and self-care intervention program, in the management of CIPN in patients receiving platinum and/or taxane-based chemotherapy.
Researchers at an NCI-designated comprehensive cancer center measured nurses' knowledge, beliefs, and skills regarding caring for LGB and transgender patients as a step toward improving health care for this patient population. Their results were presented at the 2018 ONS Annual Congress.
A nurse-education program focused on end-of-life care that is compassionate for all involved in the cancer continuum — patients, their families, and the nurses — led to a hospital-wide educational program, introducing extensive changes and collaboration among nurses.
Results of a retrospective review assessing the prevalence of chronic opioid use among patients with oropharynx cancer after surgery was presented at the 2018 American Head & Neck Society Annual Meeting.
An analysis of ESAS scores identified factors that increased the odds patients with cancer would experience greater symptom burdens and at what points in the cancer experience this was more likely to occur.
A study presented at the NACNS 2018 Annual Conference focused on redesigning CNS practice to mirror patient transitions throughout the continuum of care.
Routine screening initiative results in improved aspiration rates in multiple units across an academic medical center, according to a study presented at the NACNS 2018 Annual Conference.
Collaboration with fertility nurse specialists can improve the timeliness of fertility consultations for patients of reproductive potential with cancer, a project presented at the NACNS 2018 Annual Conference has shown.
Study results presented at the NACNS 2018 Annual Conference demonstrate the efficacy of SSI bundle element compliance and multidisciplinary clinical collaboration in reducing colon surgical site infections.
The effectiveness of twice daily screenings for delirium was investigated in a study presented at the NACNS 2018 Annual Conference.
Researchers present findings of a study assessing the value of SESM evaluations in patients with hematologic cancer prior to undergoing SCT at the NACNS 2018 Annual Conference.
A CNS-led initiative presented at the NACNS 2018 Annual Conference identified inconsistencies in oncology care, and addressed and implemented corrective measures.
Researchers sought to determine the effect of a standing order set for nutrition and assessment of hospitalized patients. Results were presented at the NACNS 2018 Annual Conference.
After assessing and addressing nurse knowledge of use of the Confusion Assessment Method (CAM) tool, implementation of screening protocol improved interventions for older hospitalized patients who had undergone urological surgery. These results were presented in a poster at the NACNS 2018 Annual Conference.
Results of a cross-over trial presented at the NACNS 2018 Annual Conference demonstrate the efficacy of antiseptic device swabs in reducing central line-associated bloodstream infections in oncology patients with central venous catheters.
Results of a pilot project that incorporated widened parameters on clinical alarms based on evidence-based recommendations were presented at the NACNS 2018 Annual Conference.
Highlights of the role for the CNS in the multidisciplinary perioperative clinical team were presented at the NACNS 2018 Annual Conference.
A revised orientation program that engaged CNS staff in new nurse orientation to the OR improved job satisfaction and staff retention.
Effectiveness of daily rounding by a multidisciplinary team on improved staff communication and outcomes-oriented, patient-centered care was presented at the 2018 NACNS Annual Conference.
Results of a project involving periodic surveys of nursing staff intended to assess familiarity with sepsis screening tool and sepsis bundle was presented at the NACNS 2018 Annual Conference.sep
CNS-led team of investigators sought to determine if air-assisted technology could reduce patient, as well as nurse, injuries incurred when repositioning patients. Results were presented at the NACNS 2018 Annual Conference.
Results of a standardized skills lab designed to ensure consistent knowledge and competency across all adult care units were presented at the NACNS 2018 Annual Conference.
SPARTAN phase 3 study shows that apalutamide prolongs metastasis-free survival and time to symptomatic progression compared with placebo among men with nonmetastatic CRPC.
Researchers present findings of a comparison of daily image-guided radiotherapy (IGRT) vs a weekly regimen in patients with N0 localized prostate cancer at the 2018 GU Cancers Symposium.
Safety and efficacy of atezolizumab with cobimetinib for heavily pretreated metastatic CRC was demonstrated in a phase 1b study that was presented at the 2018 Gastrointestinal Cancers Symposium.
Study results presented at the 2018 Gastrointestinal Cancers Symposium demonstrated the sensitivity and specificity of the CMx biomimetic platform, a novel approach to detecting CRC and precancerous lesions that could improve screening rates.
Research presented at the 2018 Gastrointestinal Cancers Symposium described benefits seen with RAMIE vs chemotherapy or chemoradiotherapy plus OTE for esophageal cancer.
Postmenopausal women with weight gain had increased risk of triple-negative breast cancer, research indicates.
In this randomized trial, investigators sought to determine the effectiveness of high-dose dexamethasone vs conventional prednisone therapy in treatment-naïve patients with ITP. Results were presented at ASH 2017.
A retrospective study, presented at ASH 2017, determined the effectiveness of aspirin in reducing risk of VTE in patients with multiple myeloma at high risk of developing VTE.
Data presented at ASH 2017 confirm that ruxolitinib improves hematocrit control, hematologic remission, and reduction in spleen size in some patients with polycythemia vera who fail hydroxyurea.
A retrospective analysis of patients with CML determined prevalence of arterial thrombotic events in those receiving nilotinib as first-line treatment and prevalence by patient age. Data were presented at ASH 2017.
Trial investigates which of 3 maintenance regimens of nab-paclitaxel has the most ideal impact on quality of life in patients with metastatic breast cancer. Results were presented at SABCS 2017.
A study from French researchers identified which people are the most likely to influence a breast cancer patient's decision whether to undergo breast reconstruction. These findings were presented at SABCS 2017.
A team from Methodist Hospital Cancer Center discuss an app developed at the facility that helps breast cancer survivors with nutrition and physical activity at SABCS 2017.
A single-center analysis demonstrates likelihood that mastalgia indicates presence of breast cancer and extensiveness of common work-up for the complaint. These findings were presented at SABCS 2017.
A team from Dana-Farber Cancer Institute describe EMBRACE, their comprehensive care program for patients with metastatic breast cancer at SABCS 2017.
Results of a study evaluating the effectiveness of bioimpedance spectroscopy in reducing incidence of chronic breast cancer-related lymphedema (BCRL) in high-risk patients with breast cancer were presented at SABCS 2017.
Researchers presented an update of findings in the GeparSepto trial, which seeks to determine whether improvements in pathologic complete response can be translated to a survival benefit, at SABCS 2017.
Novel weight reduction plan helps breast cancer survivors achieve and maintain a healthy weight and glucose level, according to a presentation at SABCS 2017.
A review of 12 antiemetic regimens identified 3 that may be more effective than conventional regimens, a study presented at SABCS 2017 has shown.
An approach for incorporating palliative care into oncologic care early after diagnosis is explained in an education session at the 2017 SABCS.
A comparison study presented at the 2017 SABCS sought to determine the effectiveness of bisphosphonates with denosumab for skeletal-related events in women with breast cancer metastases to bone.
Choosing the optimal adjuvant therapy option for a patient with early-stage HR-positive breast cancer should be a continuous discussion with the patient, according to a presentation at SABCS 2017.
Using a mouse model of HER2+ breast cancer, researchers tested the efficiency of combined epigenetic modulation and checkpoint inhibition using the histone deacetylase inhibitor ENT and antibodies for 2 checkpoint inhibitor proteins. These findings were presented at the 2017 SABCS.
A comparison of adjuvant endocrine therapies showed one option provided greater reduction in disease recurrence among premenopausal women with ER+ breast cancer.
Researchers seeking to determine whether breast cancer metastases to the brain would respond to abemaciclib presented the results of a phase 2 Simon 2-stage trial at SABCS 2017.
Ibrutinib — a Bruton tyrosine kinase inhibitor — is currently used among patients with WM who have previously received treatment. This prospective, phase 2 study sought to determine its efficacy as a first-line therapy in treatment-naive patients.
Researchers conducted a review of more than 400 patients with hormone receptor-positive breast cancer to determine if high Oncotype DX RS is associated with a greater likelihood the cancer is hereditary.
Biomarker analysis revealed markers for cardiotoxicity enabling early initiation of heart failure therapy in patients with breast cancer who were treated with chemotherapy.
Research presented at SABCS 2017 demonstrated the effect of refining the linear predictor for determining which patients with breast cancer would potentially benefit from adjuvant chemotherapy.
A retrospective analysis presented at 2017 SABCS reveals the factors that indicate a higher risk of developing brain metastases for women with HER2+ breast cancer.
Study findings presented at SABCS 2017 demonstrate that intermediate Oncotype DX scores are prognostic of overall survival for patients with early-stage breast cancer, particularly in younger women with the disease.
Researchers injected Ewing sarcoma cells into mice to determine the effects of exercise on doxorubicin efficacy and treatment-related cardiotoxicity.
Investigators randomly assigned 100 adolescents and young adults with cancer ages 12 to 25 years old 1:1 to the PRISM intervention or to non-directive usual psychosocial care.
This study evaluated the feasibility and potential efficacy of a yoga intervention for patients with NSCLC and their caregivers.
Previous studies have shown that patients with advanced cancer may experience some financial relief integrating palliative care with standard oncologic care, but these results were coincidental findings and have not yet been fully explored.
Sign Up for Free e-newsletters
- Cancer Treatment and Research: What Lies Ahead in 2019
- Helping Patients Face the Challenge of Eating Healthy During Cancer Treatment
- Continuous Therapy May Be Beneficial in Patients With Newly Diagnosed Multiple Myeloma
- Regular Physical Activity — Even Initiated Postdiagnosis — Improves Survival for Cancer Patients
- Gastrointestinal Perforation Complicates Management of Mantle Cell Lymphoma
- Brain Exercise Program Eases Chemobrain in Breast Cancer Survivors
- Hormone Therapy for Breast Cancer (Fact Sheet)
- Counseling on the Dangers of Vaping
- Radical Prostatectomy vs Active Surveillance: Results of Nearly 3 Decades of Follow-up
- Potential of Fecal Microbiota Transplantation in Managing Immunotherapy-Associated Colitis
- Ixazomib Maintenance After ASCT Improves Progression-Free, Overall Survival in Multiple Myeloma
- Evolutionary Role of Chemotherapy in Advanced Nasopharyngeal Carcinoma: A Literature-based Network Meta-analysis
- Helping Patients Face the Challenge of Eating Healthy During Cancer Treatment
- Gastrointestinal Perforation Complicates Management of Mantle Cell Lymphoma
- Modernizing Eligibility Criteria Could Increase Access to, Participation in Clinical Trials
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|